SEC Form 4 · accession 0001493152-26-041002
NUTRA PHARMA CORP · NPHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rik J Deitsch
10% Owner
Period of report
Aug 21, 2026
Accepted (ET)
Sep 1, 2026 · 3:43 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001119643
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Series B Preferred Stock | Aug 21, 2026 | G | 12,000,000 | $0.00 | D | 0 | D | |
| Common Stock | holding | — | — | — | 43,298,859 | D |
Table II — derivative securities
No Table II lines on this filing.